The Therapy with Oral Anticoagulants in Patients with Atrial Fibrillation in Outpatient and Hospital Settings (Data from RECVASA Registries)
Aim. To evaluate an incidence of oral anticoagulants (OAC) administration during longterm follow-up period in patients with atrial fibrillation (AF) enrolled in outpatient and hospital RECVASA registries.Material and methods. 3169 patients with AF were enrolled in outpatient registries RECVASA (Ryaz...
| Main Authors: | , , , , , , , , , , , , , , , , , , , , |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Столичная издательская компания
2019-09-01
|
| Series: | Рациональная фармакотерапия в кардиологии |
| Subjects: | |
| Online Access: | https://www.rpcardio.online/jour/article/view/2007 |
| _version_ | 1826949604892999680 |
|---|---|
| author | M. M. Loukianov S. Yu. Martsevich O. M. Drapkina S. S. Yakushin A. N. Vorobyev K. G. Pereverzeva A. V. Zagrebelnyy V. Val. Yakusevich V. Vl. Yakusevich E. M. Pozdnyakova T. A. Gomova E. E. Fedotova M. N Valiakhmetov V. P. Mikhin Yu. V. Maslennikova E. Y. Andreenko V. G. Klyashtorny E. V. Kudryashov E. Yu. Okshina M. A. Panagopulu S. A. Boytsov |
| author_facet | M. M. Loukianov S. Yu. Martsevich O. M. Drapkina S. S. Yakushin A. N. Vorobyev K. G. Pereverzeva A. V. Zagrebelnyy V. Val. Yakusevich V. Vl. Yakusevich E. M. Pozdnyakova T. A. Gomova E. E. Fedotova M. N Valiakhmetov V. P. Mikhin Yu. V. Maslennikova E. Y. Andreenko V. G. Klyashtorny E. V. Kudryashov E. Yu. Okshina M. A. Panagopulu S. A. Boytsov |
| author_sort | M. M. Loukianov |
| collection | DOAJ |
| description | Aim. To evaluate an incidence of oral anticoagulants (OAC) administration during longterm follow-up period in patients with atrial fibrillation (AF) enrolled in outpatient and hospital RECVASA registries.Material and methods. 3169 patients with AF were enrolled in outpatient registries RECVASA (Ryazan), RECVASA AF-Yaroslavl and hospital registries RECVASA AF (Moscow, Kursk, Tula), age 70.9±10.7 years, 43.1% men. The incidence of OAC administration was evaluated in hospital and outpatient settings, including longterm follow-up period (2-6 years).Results. OAC were administrated only in 42.2% of cases (1335 from 3169 patients; age 69.1±10.4 years, 43% men), including warfarin (817 patients; 26%) and non-vitamin K antagonist oral anticoagulants (NOAC) – 518 (16%). Patients with permanent and persistant types of AF had lower incidence of OAC administration (43% and 40%) than in cases of paroxysmal type (47.6%, p<0.05), despite of the higher СНА2DS2-VASc risk score (4.69±1.66 and 4.23±1.57 vs 3.81±1.69; р<0.05). Patients with and without history of stroke received OAC in 42.5% and 40% of cases that means no significant difference (p>0.05) contrary to the pronounced difference of thromboembolic risk in these groups (6.14±1.34 and 3.77±1.39; р<0.001). The incidence of OAC administration in hospitals (54.1%) was 2.3 times higher than before hospitalization (23.8%) and was 4.1 times higher than in outpatient registries (13.5%). During follow-up period after hospital treatment (2.3±0.9 years) this parameter decreased from 54.1% to 41.2%, but was still 1.8 times higher than before admission to the hospital. After 4 years follow-up in RECVASA (Ryazan) registry we revealed 4.4 times higher incidence of OAC administration compared with enrollment data (4.2% and 18.3%, р<0.0001). This data was confirmed by the information from outpatient medical cards of accidentally generated group (75 from 297 patients survived during follow-up period): 5.3% at baseline and 22.7% six years later.Conclusions. RECVASA registries in 5 regions of Russia revealed low incidence of OAC administration. The risk of thromboembolic events was higher in patients with AF and no OAC administration compared with patients who received OAC. Patients with paroxysmal type of AF received OAC more often than those with permanent type. There were no significant differences of incidence of OAC therapy in patients with and without history of stroke. Both questioning of patients with AF and analysis of medical cards in outpatient clinics revealed higher incidence of OAC administration after 4-6 years of follow-up compared with the stage of enrollment in registries. |
| first_indexed | 2024-03-08T14:01:28Z |
| format | Article |
| id | doaj.art-cffb8f5bb8cf4bad9b3036b762be4b08 |
| institution | Directory Open Access Journal |
| issn | 1819-6446 2225-3653 |
| language | English |
| last_indexed | 2025-02-17T22:16:54Z |
| publishDate | 2019-09-01 |
| publisher | Столичная издательская компания |
| record_format | Article |
| series | Рациональная фармакотерапия в кардиологии |
| spelling | doaj.art-cffb8f5bb8cf4bad9b3036b762be4b082024-12-04T11:48:17ZengСтоличная издательская компанияРациональная фармакотерапия в кардиологии1819-64462225-36532019-09-0115453854510.20996/1819-6446-2019-15-4-538-5451640The Therapy with Oral Anticoagulants in Patients with Atrial Fibrillation in Outpatient and Hospital Settings (Data from RECVASA Registries)M. M. Loukianov0S. Yu. Martsevich1O. M. Drapkina2S. S. Yakushin3A. N. Vorobyev4K. G. Pereverzeva5A. V. Zagrebelnyy6V. Val. Yakusevich7V. Vl. Yakusevich8E. M. Pozdnyakova9T. A. Gomova10E. E. Fedotova11M. N Valiakhmetov12V. P. Mikhin13Yu. V. Maslennikova14E. Y. Andreenko15V. G. Klyashtorny16E. V. Kudryashov17E. Yu. Okshina18M. A. Panagopulu19S. A. Boytsov20National Medical Research Center for Preventive MedicineNational Medical Research Center for Preventive MedicineNational Medical Research Center for Preventive MedicineRyazan State Medical University named after Academician I.P. PavlovRyazan State Medical University named after Academician I.P. PavlovRyazan State Medical University named after Academician I.P. PavlovNational Medical Research Center for Preventive MedicineYaroslavl State Medical University.Yaroslavl State Medical University.Yaroslavl State Medical University.Tula Regional Clinical HospitalTula Regional Clinical HospitalCity hospital №3 of TulaKursk State Medical UniversityKursk State Medical UniversityNational Medical Research Center for Preventive MedicineNational Medical Research Center for Preventive MedicineNational Medical Research Center for Preventive MedicineNational Medical Research Center for Preventive MedicineNational Medical Research Center for Preventive MedicineNational Medical Research Center of CardiologyAim. To evaluate an incidence of oral anticoagulants (OAC) administration during longterm follow-up period in patients with atrial fibrillation (AF) enrolled in outpatient and hospital RECVASA registries.Material and methods. 3169 patients with AF were enrolled in outpatient registries RECVASA (Ryazan), RECVASA AF-Yaroslavl and hospital registries RECVASA AF (Moscow, Kursk, Tula), age 70.9±10.7 years, 43.1% men. The incidence of OAC administration was evaluated in hospital and outpatient settings, including longterm follow-up period (2-6 years).Results. OAC were administrated only in 42.2% of cases (1335 from 3169 patients; age 69.1±10.4 years, 43% men), including warfarin (817 patients; 26%) and non-vitamin K antagonist oral anticoagulants (NOAC) – 518 (16%). Patients with permanent and persistant types of AF had lower incidence of OAC administration (43% and 40%) than in cases of paroxysmal type (47.6%, p<0.05), despite of the higher СНА2DS2-VASc risk score (4.69±1.66 and 4.23±1.57 vs 3.81±1.69; р<0.05). Patients with and without history of stroke received OAC in 42.5% and 40% of cases that means no significant difference (p>0.05) contrary to the pronounced difference of thromboembolic risk in these groups (6.14±1.34 and 3.77±1.39; р<0.001). The incidence of OAC administration in hospitals (54.1%) was 2.3 times higher than before hospitalization (23.8%) and was 4.1 times higher than in outpatient registries (13.5%). During follow-up period after hospital treatment (2.3±0.9 years) this parameter decreased from 54.1% to 41.2%, but was still 1.8 times higher than before admission to the hospital. After 4 years follow-up in RECVASA (Ryazan) registry we revealed 4.4 times higher incidence of OAC administration compared with enrollment data (4.2% and 18.3%, р<0.0001). This data was confirmed by the information from outpatient medical cards of accidentally generated group (75 from 297 patients survived during follow-up period): 5.3% at baseline and 22.7% six years later.Conclusions. RECVASA registries in 5 regions of Russia revealed low incidence of OAC administration. The risk of thromboembolic events was higher in patients with AF and no OAC administration compared with patients who received OAC. Patients with paroxysmal type of AF received OAC more often than those with permanent type. There were no significant differences of incidence of OAC therapy in patients with and without history of stroke. Both questioning of patients with AF and analysis of medical cards in outpatient clinics revealed higher incidence of OAC administration after 4-6 years of follow-up compared with the stage of enrollment in registries.https://www.rpcardio.online/jour/article/view/2007atrial fibrillationregistriestherapy with oral anticoagulantswarfarinnon-vitamin k antagonist oral anticoagulantoutpatient and hospital settingsfollow-up |
| spellingShingle | M. M. Loukianov S. Yu. Martsevich O. M. Drapkina S. S. Yakushin A. N. Vorobyev K. G. Pereverzeva A. V. Zagrebelnyy V. Val. Yakusevich V. Vl. Yakusevich E. M. Pozdnyakova T. A. Gomova E. E. Fedotova M. N Valiakhmetov V. P. Mikhin Yu. V. Maslennikova E. Y. Andreenko V. G. Klyashtorny E. V. Kudryashov E. Yu. Okshina M. A. Panagopulu S. A. Boytsov The Therapy with Oral Anticoagulants in Patients with Atrial Fibrillation in Outpatient and Hospital Settings (Data from RECVASA Registries) Рациональная фармакотерапия в кардиологии atrial fibrillation registries therapy with oral anticoagulants warfarin non-vitamin k antagonist oral anticoagulant outpatient and hospital settings follow-up |
| title | The Therapy with Oral Anticoagulants in Patients with Atrial Fibrillation in Outpatient and Hospital Settings (Data from RECVASA Registries) |
| title_full | The Therapy with Oral Anticoagulants in Patients with Atrial Fibrillation in Outpatient and Hospital Settings (Data from RECVASA Registries) |
| title_fullStr | The Therapy with Oral Anticoagulants in Patients with Atrial Fibrillation in Outpatient and Hospital Settings (Data from RECVASA Registries) |
| title_full_unstemmed | The Therapy with Oral Anticoagulants in Patients with Atrial Fibrillation in Outpatient and Hospital Settings (Data from RECVASA Registries) |
| title_short | The Therapy with Oral Anticoagulants in Patients with Atrial Fibrillation in Outpatient and Hospital Settings (Data from RECVASA Registries) |
| title_sort | therapy with oral anticoagulants in patients with atrial fibrillation in outpatient and hospital settings data from recvasa registries |
| topic | atrial fibrillation registries therapy with oral anticoagulants warfarin non-vitamin k antagonist oral anticoagulant outpatient and hospital settings follow-up |
| url | https://www.rpcardio.online/jour/article/view/2007 |
| work_keys_str_mv | AT mmloukianov thetherapywithoralanticoagulantsinpatientswithatrialfibrillationinoutpatientandhospitalsettingsdatafromrecvasaregistries AT syumartsevich thetherapywithoralanticoagulantsinpatientswithatrialfibrillationinoutpatientandhospitalsettingsdatafromrecvasaregistries AT omdrapkina thetherapywithoralanticoagulantsinpatientswithatrialfibrillationinoutpatientandhospitalsettingsdatafromrecvasaregistries AT ssyakushin thetherapywithoralanticoagulantsinpatientswithatrialfibrillationinoutpatientandhospitalsettingsdatafromrecvasaregistries AT anvorobyev thetherapywithoralanticoagulantsinpatientswithatrialfibrillationinoutpatientandhospitalsettingsdatafromrecvasaregistries AT kgpereverzeva thetherapywithoralanticoagulantsinpatientswithatrialfibrillationinoutpatientandhospitalsettingsdatafromrecvasaregistries AT avzagrebelnyy thetherapywithoralanticoagulantsinpatientswithatrialfibrillationinoutpatientandhospitalsettingsdatafromrecvasaregistries AT vvalyakusevich thetherapywithoralanticoagulantsinpatientswithatrialfibrillationinoutpatientandhospitalsettingsdatafromrecvasaregistries AT vvlyakusevich thetherapywithoralanticoagulantsinpatientswithatrialfibrillationinoutpatientandhospitalsettingsdatafromrecvasaregistries AT empozdnyakova thetherapywithoralanticoagulantsinpatientswithatrialfibrillationinoutpatientandhospitalsettingsdatafromrecvasaregistries AT tagomova thetherapywithoralanticoagulantsinpatientswithatrialfibrillationinoutpatientandhospitalsettingsdatafromrecvasaregistries AT eefedotova thetherapywithoralanticoagulantsinpatientswithatrialfibrillationinoutpatientandhospitalsettingsdatafromrecvasaregistries AT mnvaliakhmetov thetherapywithoralanticoagulantsinpatientswithatrialfibrillationinoutpatientandhospitalsettingsdatafromrecvasaregistries AT vpmikhin thetherapywithoralanticoagulantsinpatientswithatrialfibrillationinoutpatientandhospitalsettingsdatafromrecvasaregistries AT yuvmaslennikova thetherapywithoralanticoagulantsinpatientswithatrialfibrillationinoutpatientandhospitalsettingsdatafromrecvasaregistries AT eyandreenko thetherapywithoralanticoagulantsinpatientswithatrialfibrillationinoutpatientandhospitalsettingsdatafromrecvasaregistries AT vgklyashtorny thetherapywithoralanticoagulantsinpatientswithatrialfibrillationinoutpatientandhospitalsettingsdatafromrecvasaregistries AT evkudryashov thetherapywithoralanticoagulantsinpatientswithatrialfibrillationinoutpatientandhospitalsettingsdatafromrecvasaregistries AT eyuokshina thetherapywithoralanticoagulantsinpatientswithatrialfibrillationinoutpatientandhospitalsettingsdatafromrecvasaregistries AT mapanagopulu thetherapywithoralanticoagulantsinpatientswithatrialfibrillationinoutpatientandhospitalsettingsdatafromrecvasaregistries AT saboytsov thetherapywithoralanticoagulantsinpatientswithatrialfibrillationinoutpatientandhospitalsettingsdatafromrecvasaregistries AT mmloukianov therapywithoralanticoagulantsinpatientswithatrialfibrillationinoutpatientandhospitalsettingsdatafromrecvasaregistries AT syumartsevich therapywithoralanticoagulantsinpatientswithatrialfibrillationinoutpatientandhospitalsettingsdatafromrecvasaregistries AT omdrapkina therapywithoralanticoagulantsinpatientswithatrialfibrillationinoutpatientandhospitalsettingsdatafromrecvasaregistries AT ssyakushin therapywithoralanticoagulantsinpatientswithatrialfibrillationinoutpatientandhospitalsettingsdatafromrecvasaregistries AT anvorobyev therapywithoralanticoagulantsinpatientswithatrialfibrillationinoutpatientandhospitalsettingsdatafromrecvasaregistries AT kgpereverzeva therapywithoralanticoagulantsinpatientswithatrialfibrillationinoutpatientandhospitalsettingsdatafromrecvasaregistries AT avzagrebelnyy therapywithoralanticoagulantsinpatientswithatrialfibrillationinoutpatientandhospitalsettingsdatafromrecvasaregistries AT vvalyakusevich therapywithoralanticoagulantsinpatientswithatrialfibrillationinoutpatientandhospitalsettingsdatafromrecvasaregistries AT vvlyakusevich therapywithoralanticoagulantsinpatientswithatrialfibrillationinoutpatientandhospitalsettingsdatafromrecvasaregistries AT empozdnyakova therapywithoralanticoagulantsinpatientswithatrialfibrillationinoutpatientandhospitalsettingsdatafromrecvasaregistries AT tagomova therapywithoralanticoagulantsinpatientswithatrialfibrillationinoutpatientandhospitalsettingsdatafromrecvasaregistries AT eefedotova therapywithoralanticoagulantsinpatientswithatrialfibrillationinoutpatientandhospitalsettingsdatafromrecvasaregistries AT mnvaliakhmetov therapywithoralanticoagulantsinpatientswithatrialfibrillationinoutpatientandhospitalsettingsdatafromrecvasaregistries AT vpmikhin therapywithoralanticoagulantsinpatientswithatrialfibrillationinoutpatientandhospitalsettingsdatafromrecvasaregistries AT yuvmaslennikova therapywithoralanticoagulantsinpatientswithatrialfibrillationinoutpatientandhospitalsettingsdatafromrecvasaregistries AT eyandreenko therapywithoralanticoagulantsinpatientswithatrialfibrillationinoutpatientandhospitalsettingsdatafromrecvasaregistries AT vgklyashtorny therapywithoralanticoagulantsinpatientswithatrialfibrillationinoutpatientandhospitalsettingsdatafromrecvasaregistries AT evkudryashov therapywithoralanticoagulantsinpatientswithatrialfibrillationinoutpatientandhospitalsettingsdatafromrecvasaregistries AT eyuokshina therapywithoralanticoagulantsinpatientswithatrialfibrillationinoutpatientandhospitalsettingsdatafromrecvasaregistries AT mapanagopulu therapywithoralanticoagulantsinpatientswithatrialfibrillationinoutpatientandhospitalsettingsdatafromrecvasaregistries AT saboytsov therapywithoralanticoagulantsinpatientswithatrialfibrillationinoutpatientandhospitalsettingsdatafromrecvasaregistries |